GSK Plc (GSK)
50.45
-0.19
(-0.38%)
USD |
NYSE |
Nov 13, 16:00
50.46
+0.02
(+0.03%)
After-Hours: 19:59
GSK Price to Book Value : 4.059 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.059 |
| November 12, 2026 | 4.074 |
| November 11, 2026 | 4.071 |
| November 10, 2026 | 4.122 |
| November 09, 2026 | 4.147 |
| November 06, 2026 | 4.049 |
| November 05, 2026 | 4.056 |
| November 04, 2026 | 4.115 |
| November 03, 2026 | 3.918 |
| November 02, 2026 | 3.953 |
| October 30, 2026 | 3.984 |
| October 29, 2026 | 3.917 |
| October 28, 2026 | 3.922 |
| October 27, 2026 | 4.098 |
| October 26, 2026 | 4.111 |
| October 23, 2026 | 4.083 |
| October 22, 2026 | 4.120 |
| October 21, 2026 | 4.024 |
| October 20, 2026 | 4.074 |
| October 19, 2026 | 3.979 |
| October 16, 2026 | 3.984 |
| October 15, 2026 | 3.944 |
| October 14, 2026 | 3.852 |
| October 13, 2026 | 3.723 |
| October 12, 2026 | 3.775 |
| Date | Value |
|---|---|
| October 09, 2026 | 3.741 |
| October 08, 2026 | 3.744 |
| October 07, 2026 | 3.783 |
| October 06, 2026 | 3.749 |
| October 05, 2026 | 3.745 |
| October 02, 2026 | 3.784 |
| October 01, 2026 | 3.796 |
| September 30, 2026 | 3.876 |
| September 29, 2026 | 4.262 |
| September 28, 2026 | 4.292 |
| September 25, 2026 | 4.253 |
| September 24, 2026 | 4.288 |
| September 23, 2026 | 4.293 |
| September 22, 2026 | 4.381 |
| September 21, 2026 | 4.412 |
| September 18, 2026 | 4.337 |
| September 17, 2026 | 4.41 |
| September 16, 2026 | 4.344 |
| September 15, 2026 | 4.319 |
| September 14, 2026 | 4.323 |
| September 11, 2026 | 4.157 |
| September 10, 2026 | 4.156 |
| September 09, 2026 | 4.200 |
| September 08, 2026 | 4.192 |
| September 04, 2026 | 4.309 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 12.09 |
| Johnson & Johnson | 8.437 |
| Eli Lilly & Co. | 33.74 |
| Merck & Co., Inc. | 8.119 |
| Novo Nordisk A/S | 5.561 |
Price to Book Value Related Metrics
| PE Ratio | 17.59 |
| PS Ratio | 2.285 |
| Price to Free Cash Flow | 13.09 |
| Price | 50.45 |
| Earnings Yield | 5.69% |
| Market Cap | 101.13B |
| Operating PE Ratio | 9.237 |
| Normalized PE Ratio | 11.10 |